Shapely review
The membership and the medication are two separate charges, and the site says so.
The verdict
Shapely is an insurance-navigation service before it is a compounded GLP-1 seller. Its self-pay membership is $99 a month, and the panel listing what that membership covers also lists what it does not: medications and labs. A buyer paying cash for compounded semaglutide pays the medication rate and the membership, not one or the other.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 4
- From
- From $198/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Labs
- Extra cost
- Availability
- 4 states
Shapely is a telehealth weight-loss practice in network with Medicare and major PPO plans. Its catalog leads with brand GLP-1s marked insurance-accepted, and lists compounded semaglutide and tirzepatide as cash-pay only. Video visits with a provider and a registered dietitian are the core of the service. Eligibility is stated for adults in four states.
Who writes the prescription, and what do they see?
Care is delivered over video with an assigned provider, not through a questionnaire alone, and a dietitian visit is described monthly. The site states a provider may determine a compounded medication is clinically appropriate, which places the compounded route as a fallback rather than the default. Recent labs are strongly recommended but not required before starting most medications.
Members get monthly video visits, unlimited chat, and a cellular scale that reports weight automatically, though the scale is excluded on two named insurers. Coverage is verified before any plan is chosen. Concierge support for locating medication at local pharmacies is stated to be part of the membership. Labs are offered at a flat rate for the uninsured.
What happens when the dose goes up?
Compounded pricing is described as tiered by dose, with named ranges for low-mid and high doses. That is unusual disclosure, and it also means the medication charge rises as the dose climbs. Nothing states who signs off each step. No milligram figure appears beside any tier.
What the price includes
Compounded semaglutide is $99 a month on both its starter and refill packages, billed $297 a quarter. Tirzepatide is $199 a month on the refill package, billed $597, after a $166 starter package; the high-dose package is $279. The membership is $99 a month, discounted for a first month, and is charged whether or not a plan covers the medication. Insurance copays for brand medications are described as typically $25, depending on the plan. Labs are $75 without insurance.
What it claims, and what it cites
Brand Ozempic, Wegovy, Zepbound, Mounjaro, Contrave and an orforglipron tablet are listed alongside the compounded lines. The compounded preparations come from a state-licensed pharmacy and are not FDA-approved. Shapely states it is not affiliated with either manufacturer's own patient program, while helping members reach them.
Where it holds up, and where it does not
- Strength: In network with Medicare and major PPO plans
- Strength: Video visits with a provider and a dietitian
- Strength: Brand and compounded routes sit side by side
- Strength: Dose tiers are described rather than hidden
- Strength: Lab cost is published for the uninsured
- Limitation: Eligibility is limited to four states
- Limitation: The membership excludes the medication
- Limitation: Medication is billed three months at a time
- Limitation: The medication charge rises with the dose
- Limitation: Testimonials are compensated for usage rights
What the evidence says about this kind of treatment
The assessment above is about Shapely. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- An insured buyer in one of its four states who wants coverage checked before paying cash.
- Wrong for
- A cash-pay buyer expecting the advertised medication rate to be the whole bill.
The evidence behind what Shapely prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Shapely compares
| Seller | Who it suits | Go |
|---|---|---|
| Buyers comparing a compounded plan against the brand routes on the same catalog page | See Zappy Health → | |
| CLYR Health | Buyers who want the cost of each dose tier published before the first injection | See CLYR Health → |
| Buyers who want the renewal rate printed beside the introductory one, on every plan | See EOS Health → |
More GLP-1 telehealth sellers reviews: SynergenX HealthSynergy RxT2D.comTD Tele-Doc Weight LossTeleCareSpotTeleClinic
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does the $99 membership include medication?
- No. Shapely's own panel lists medications and labs among the things a membership does not include, so the two are billed separately.
- Which states does Shapely serve?
- Its eligibility answer names four: California, Florida, New York and Texas. The rest are described as coming.
- Is compounded the default here?
- No. Insurance-covered brand medication is the first route, and the site describes compounded as what a provider may determine is appropriate instead.
- Is Shapely legit?
- Shapely is a GLP-1 telehealth sellers service. Its stated availability: 4 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Shapely expensive compared with other GLP-1 telehealth sellers?
- Shapely publishes a starting figure of $198/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Shapely above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.